Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine effects on cerebral autoregulation and oxygenation in aneurysmal subarachnoid hemorrhage
2012-000068-11Phase 4Completed
- Sponsor
- Turku University Hospital
- Start
- Apr 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of dexmedetomidine in subarachnoid hemorrhage (SAH), sponsored by Turku University Hospital. Primary endpoint: Effect of dexmedetomidine on cerebral autoregulation. Started Apr 2012; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on 2012-000068-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000068-11.